Rigel Pharma’s Treatment for a type of Leukemia approved by US FDA
The drug developed by Rigel Pharmaceuticals has been granted approval by the US Food and Drug Administration (FDA) to be used in the treatment of a type of leukemia. As a result, Rigel Pharmaceuticals’ shares have increased by 14% during extended trading. The medicine that will be sold under the brand name Rezlidhia has been […]
Continue Reading